Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis
Authors
Keywords
Bimodal liquid biopsy, Peptide engineering, Cancer immunotherapy, Circulating tumor cells, Exosomes
Journal
BIOSENSORS & BIOELECTRONICS
Volume -, Issue -, Pages 114445
Publisher
Elsevier BV
Online
2022-06-01
DOI
10.1016/j.bios.2022.114445
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Dual-Channel Intelligent Point-of-Care Testing System for Soluble Programmed Death-1 and Programmed Death-Ligand 1 Detection Based on Folding Paper-Based Immunosensors
- (2022) Yu Xing et al. ACS Sensors
- Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)
- (2022) Taehee Lee et al. Cancers
- New electrochemical method for programmed death-ligand 1 detection based on a paper-based microfluidic aptasensor
- (2021) Yu Xing et al. BIOELECTROCHEMISTRY
- Tri‐modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell‐free DNA using machine learning algorithm
- (2021) Jiyoon Bu et al. Clinical and Translational Medicine
- Hierarchically Multivalent Peptide–Nanoparticle Architectures: A Systematic Approach to Engineer Surface Adhesion
- (2021) Woo‐jin Jeong et al. Advanced Science
- Nanoparticle Conjugation Stabilizes and Multimerizes β-Hairpin Peptides To Effectively Target PD-1/PD-L1 β-Sheet-Rich Interfaces
- (2020) Woo-jin Jeong et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
- (2020) Yanxiao Han et al. ACS Nano
- Immunoavidity-Based Capture of Tumor Exosomes Using Poly(amidoamine) Dendrimer Surfaces
- (2020) Michael J. Poellmann et al. NANO LETTERS
- Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application
- (2020) Jiyoon Bu et al. BIOSENSORS & BIOELECTRONICS
- An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy
- (2020) Jiyoon Bu et al. NANO LETTERS
- Multi-modal liquid biopsy platform for cancer screening: screening both cancer-associated rare cells and cancer cell-derived vesicles on the fabric filters for a reliable liquid biopsy analysis
- (2019) Jiyoon Bu et al. Nano Convergence
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Computational studies of micellar and nanoparticle nanomedicines
- (2018) Soumyo Sen et al. CHEMICAL SOCIETY REVIEWS
- Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture
- (2018) Ja Hye Myung et al. CLINICAL CANCER RESEARCH
- The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?
- (2018) Keith M. Kerr Journal of Thoracic Oncology
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
- (2018) H. Halse et al. Scientific Reports
- Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy
- (2018) Chunyan Yue et al. OncoImmunology
- Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
- (2018) Jianming Xu et al. CLINICAL CANCER RESEARCH
- Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
- (2018) Marcin Kowanetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism
- (2017) Valeria Cagno et al. NATURE MATERIALS
- Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid β-Protein Aggregation and Cytotoxicity
- (2017) Neng Xiong et al. Small
- Protein conformational flexibility modulates kinetics and thermodynamics of drug binding
- (2017) M. Amaral et al. Nature Communications
- Enhancement of isolation sensitivity for the viable heterogeneous circulating tumor cells swelled by hypo-osmotic pressure
- (2017) Jiyoon Bu et al. RSC Advances
- Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
- (2016) Archana Anantharaman et al. BMC CANCER
- Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents: A meta-analysis
- (2016) Omar Abdel-Rahman CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- PD-L1 Expression in Lung Cancer
- (2016) Hui Yu et al. Journal of Thoracic Oncology
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies
- (2016) Angela Esposito et al. PHARMACOLOGY & THERAPEUTICS
- Hydrocarbon constrained peptides – understanding preorganisation and binding affinity
- (2016) Jennifer A. Miles et al. Chemical Science
- Effective Capture of Circulating Tumor Cells from a Transgenic Mouse Lung Cancer Model Using Dendrimer Surfaces Immobilized with Anti-EGFR
- (2015) Ja Hye Myung et al. ANALYTICAL CHEMISTRY
- Relative Cosolute Size Influences the Kinetics of Protein-Protein Interactions
- (2015) Laurel Hoffman et al. BIOPHYSICAL JOURNAL
- Frequent expression of PD-L1 on circulating breast cancer cells
- (2015) Martine Mazel et al. Molecular Oncology
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells
- (2015) Joao Paulo Oliveira-Costa et al. Oncotarget
- Multiplexing Natural Orientation: Oppositely Directed Self-Assembling Peptides
- (2014) Woo-jin Jeong et al. BIOMACROMOLECULES
- Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
- (2014) Gunnar Steinert et al. CANCER RESEARCH
- Coupled Folding and Binding of the Disordered Protein PUMA Does Not Require Particular Residual Structure
- (2014) Joseph M. Rogers et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Poly(ethylene glycol) Corona Chain Length Controls End-Group-Dependent Cell Interactions of Dendron Micelles
- (2014) Hao-jui Hsu et al. MACROMOLECULES
- Interplay between partner and ligand facilitates the folding and binding of an intrinsically disordered protein
- (2014) J. M. Rogers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peptide-based isolation of circulating tumor cells by magnetic nanoparticles
- (2014) Linling Bai et al. Journal of Materials Chemistry B
- Interpreting the widespread nonlinear force spectra of intermolecular bonds
- (2012) R. W. Friddle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduction of Non-Specific Protein Adsorption Using Poly(ethylene) Glycol (PEG) Modified Polyacrylate Hydrogels In Immunoassays for Staphylococcal Enterotoxin B Detection
- (2009) Paul Charles et al. SENSORS
- Covalent functionalization of NiTi surfaces with bioactive peptide amphiphile nanofibers
- (2007) Timothy D. Sargeant et al. BIOMATERIALS
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now